Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation
Top Cited Papers
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (13) , 12876-12882
- https://doi.org/10.1074/jbc.m311652200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP CleavagesBiochemistry, 2003
- E-cadherin-mediated interactions of thymic epithelial cells with CD103+ thymocytes lead to enhanced thymocyte cell proliferationJournal of Cell Science, 2002
- Presenilin-dependent Intramembrane Proteolysis of CD44 Leads to the Liberation of Its Intracellular Domain and the Secretion of an Aβ-like PeptideJournal of Biological Chemistry, 2002
- Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cellsNature Immunology, 2002
- An Invitation to T and More: Notch Signaling in LymphopoiesisCell, 2002
- Biochemical Characterization of the γ-Secretase Activity That Produces β-Amyloid PeptidesBiochemistry, 2001
- Mutant Presenilin 2 Transgenic MicePublished by Elsevier ,2000
- Notch Signaling: Cell Fate Control and Signal Integration in DevelopmentScience, 1999
- Involvement of E-Cadherin in Thymus Organogenesisand Thymocyte MaturationImmunity, 1997
- Correlations of synaptic and pathological markers with cognition of the elderlyNeurobiology of Aging, 1995